These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35806381)

  • 1. Oncogenic Signalling of Growth Factor Receptors in Cancer: Mechanisms and Therapeutic Opportunities.
    Dricu A
    Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncogenes and cancer suppressor genes.
    Yarbro JW
    Semin Oncol Nurs; 1992 Feb; 8(1):30-9. PubMed ID: 1546217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Growth factors and oncogenes in development and carcinogenesis. Role of the epidermal growth factor system].
    Paci A; Ciarimboli G; Ferdeghini M
    Minerva Med; 1994 Sep; 85(9):467-90. PubMed ID: 7936369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-oncogenic and anti-oncogenic pathways: opportunities and challenges of cancer therapy.
    Zhang J; Chen YH; Lu Q
    Future Oncol; 2010 Apr; 6(4):587-603. PubMed ID: 20373871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor (PDGF) signalling in cancer: rapidly emerging signalling landscape.
    Farooqi AA; Siddik ZH
    Cell Biochem Funct; 2015 Jul; 33(5):257-65. PubMed ID: 26153649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LTβR signalling preferentially accelerates oncogenic AKT-initiated liver tumours.
    Scarzello AJ; Jiang Q; Back T; Dang H; Hodge D; Hanson C; Subleski J; Weiss JM; Stauffer JK; Chaisaingmongkol J; Rabibhadana S; Ruchirawat M; Ortaldo J; Wang XW; Norris PS; Ware CF; Wiltrout RH
    Gut; 2016 Oct; 65(10):1765-75. PubMed ID: 26206664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction by the oncogenic receptor tyrosine kinase Xmrk in melanoma formation of Xiphophorus.
    Wellbrock C; Gómez A; Schartl M
    Pigment Cell Res; 1997; 10(1-2):34-40. PubMed ID: 9170160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.
    Fields AP; Frederick LA; Regala RP
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [FGF/FGFR signalling: Implication in oncogenesis and perspectives].
    Flippot R; Kone M; Magné N; Vignot S
    Bull Cancer; 2015 Jun; 102(6):516-26. PubMed ID: 25986739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis.
    Zhang J; Tang PMK; Zhou Y; Cheng ASL; Yu J; Kang W; To KF
    Cells; 2019 Jun; 8(6):. PubMed ID: 31242658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in DNA Damage Response, Carcinogenesis, and Chemoresistance.
    Fang Y; Zhang L; Li Z; Li Y; Huang C; Lu X
    Int Rev Cell Mol Biol; 2017; 333():1-49. PubMed ID: 28729023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting molecular addictions in cancer.
    Vivanco I
    Br J Cancer; 2014 Nov; 111(11):2033-8. PubMed ID: 25268375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mammary gland oncogenes as indicators of pathways important in mammary gland development.
    Dickson C; Creer A; Fantl V
    Oncogene; 2000 Feb; 19(8):1097-101. PubMed ID: 10713696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The c-MYC-BMI1 axis is essential for SETDB1-mediated breast tumourigenesis.
    Xiao JF; Sun QY; Ding LW; Chien W; Liu XY; Mayakonda A; Jiang YY; Loh XY; Ran XB; Doan NB; Castor B; Chia D; Said JW; Tan KT; Yang H; Fu XY; Lin DC; Koeffler HP
    J Pathol; 2018 Sep; 246(1):89-102. PubMed ID: 29926931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenes in cell survival and cell death.
    Shortt J; Johnstone RW
    Cold Spring Harb Perspect Biol; 2012 Dec; 4(12):. PubMed ID: 23209150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hidden Targets in RAF Signalling Pathways to Block Oncogenic RAS Signalling.
    Nolan AA; Aboud NK; Kolch W; Matallanas D
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33920182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
    Carrella D; Manni I; Tumaini B; Dattilo R; Papaccio F; Mutarelli M; Sirci F; Amoreo CA; Mottolese M; Iezzi M; Ciolli L; Aria V; Bosotti R; Isacchi A; Loreni F; Bardelli A; Avvedimento VE; di Bernardo D; Cardone L
    Oncotarget; 2016 Sep; 7(37):58743-58758. PubMed ID: 27542212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What we need to know about cancer genes.
    Leong AS; Leong FJ
    Diagn Cytopathol; 1998 Jan; 18(1):33-40. PubMed ID: 9451556
    [No Abstract]   [Full Text] [Related]  

  • 19. PERK Integrates Oncogenic Signaling and Cell Survival During Cancer Development.
    Bu Y; Diehl JA
    J Cell Physiol; 2016 Oct; 231(10):2088-96. PubMed ID: 26864318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of FGFR in oral carcinogenesis.
    Xie X; Wang Z; Chen F; Yuan Y; Wang J; Liu R; Chen Q
    Cell Prolif; 2016 Jun; 49(3):261-9. PubMed ID: 27218663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.